Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation

Haematologica

Volumn 91, Issue 12, 2006, Pages 1693-1696

  Sagaert, Xavier ^a,c   Theys, Tom ^a   De Wolf Peeters, Christiane ^a   Marynen, Peter ^b   Baens, Mathijs ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

Author keywords

API2 MALT1; Immune response; Malt lymphoma

Indexed keywords

HYBRID PROTEIN; HYBRID PROTEIN AP12 MALT1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, FUSION; SPLENIC NEOPLASMS;

EID: 33845947934     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jaffe E, Harris N, Stein H, Vardiman J. World Health Organisation Classification of Tumours: Pathology and Genetics: Tumours of Haemopoietic and Lymphoid Tissues. Lyon, France: IAR Press. 2004.
2. Baens M, Steyls A, Geboes K, Marynen P, Wolf-Peeters C. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000;156:1433-9.
3. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of AP12-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000;156:1183-8.
4. Sagaert X, Laurent M, Baens M, Wlodarska I, De Wolf-Peeters C. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells. Mod Pathol 2006;19:225-32.
5. Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004;18:1722-6.
6. Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-9.
7. Uren AG, O'Rourke K, Aravind L, Pisabarro MT, Seshagiri S, Koonin EV et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 2000;6:961-7.
8. Muller-Hermelink HK. Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas: marginal zone lymphomas. Hum Pathol 2003;34:336-40.
9. Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V, et al. Selective expansion of marginal zone B cells in E mu-API2-MALT1 mice is linked to enhanced I kappa B kinase γ polyubiquitination. Cancer Res 2006;66:5270-7.
10. Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001;70:849-60.
11. Maes B, Achten R, Demunter A, Peeters B, Verhoef G, De Wolf-Peeters C. Evaluation of B cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemistry, and molecular analysis. J Clin Pathol 2000;53:835-40.
12. Fredrickson TN, Lennert K, Chattopadhyay SK, Morse HC, Hartley JW. Splenic marginal zone lymphomas of mice. Am J Pathol 1999;154:805-12.
13. Morse HC, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-58.
14. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood 2003;101:2464-72.
15. Thieblemont C, Felman F, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003;4:95-103.
16. Morse HC, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES. Cells of the marginal zone-origins, function and neoplasia. Leukemia Res 2001;25:169-78.
17. Mahler JF, Stokes W, Mann FC, Takaoka M, Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 1996;24:710-6.
18. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid-tissue type after cure of Helicobacter-pylori infection. Lancet 1995;345:1591-4.
19. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial. Ann Intern Med 1999;131:88-95.
20. Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, de Boni M, Doglioni C. Long-term follow-up of gastric MALT lymphoma treated by eradication of H-pylori with antibodies. Gastroenterology 1999;117:750-1.